News Room

Press Releases

March 16, 2018
WASHINGTON—As the Trump administration prepares to take action against unfair Chinese trade practices under its Section 301 review, all options, including tariffs, appear to be on the table.
March 15, 2018
“Big Is Beautiful: Debunking the Myth of Small Business,” by Robert D. Atkinson and Michael Lind
March 5, 2018
WASHINGTON—While income inequality is rightly a cause for concern in the United States, influential analyses by leading economists have dramatically overstated the trend in disparities between the
February 28, 2018
WASHINGTON—The Information Technology and Innovation Foundation (ITIF), the world’s leading science and tech policy think tank, today applauded the announcement from Federal Communications Co


News Clips

April 20, 2018
“Those are programs that make a lot of sense because they help the kind of firms that we want to grow and that could create a lot of jobs,” said ITIF President Robert Atkinson.
April 17, 2018
“There definitely is some countervailing loss to rural broadband deployment, if only because the Chinese equipment is generally pretty cheap,” ITIF’s Doug Brake told National Journal. “So there is definitely a trade-off. And it’s hard to say if it’s worth it when there’s still so little known publicly about what the national security threat actually is.”
April 12, 2018
The Economist notes that ITIF President Rob Atkinson accuses the Chinese of playing rope-a-dope, allowing the American administration to exhaust itself in ultimately futile complaints. He thinks that it should give up on the rules and focus instead on results, for example by arranging for American firms to inform it “off the record” of Chinese infractions.
April 10, 2018
Anonymized data collection “doesn’t create a lot of harm and can create some significant benefits,” ITIF’s Joe Kennedy told the Associated Press. He cited targeted ads as a boon to consumers and said the data behind them can boost artificial intelligence systems, which use vast quantities of data to “learn” human-like behavior.
April 10, 2018
Trump’s April 5 directive signals an “opening move in a chess match designed to attain some negotiating leverage with China,” ITIF’s Stephen Ezell told Bloomberg BNA. “If we came to a point in three to six months where tariffs on those products were applied, that would potentially disrupt an innovation ecosystem and the life sciences on both sides of the Pacific. It could raise prices for patients, potentially.”